It is believed around 1,700 people could be eligible for the treatment, while the NHS estimates around 50 people a year will ...

Sickle cell anaemia is a genetic blood disorder characterised by the production of an abnormal haemoglobin, known as ...

A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in ...

Vertex Pharma's £1.65 million ($2.05 million) gene-editing therapy for sickle cell disease (SCD), Casgevy, has been given the ...

A cutting-edge gene therapy has been approved for NHS use for some patients with severe sickle cell disease. Casgevy, also ...

The National Health Service (NHS) has approved a groundbreaking £1.65 million treatment for sickle cell disease in England, ...

The Guardian UK newspaper of January 31, 2025, stated, “A groundbreaking £1.65m treatment offering a potential cure for people in England living with sickle cell disease has been approved for ...

A "groundbreaking" £1.65 million treatment has been approved for use on the NHS, offering patients with severe sickle cell disease some hope of a cure. It is believed around 1,700 people could be ...

NHS patients with sickle cell disease will be able to benefit from a groundbreaking gene-editing treatment that offers the prospect of a cure for the condition. The one-off gene therapy, known as ...

A lab technician conducts an electrophoresis test during a free sickle cell screening medical camp in Nairobi. Treatment for the disease has been approved for use in England for older children and ...